Ardelyx Inc
General ticker "ARDX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $1.2B
Ardelyx Inc does not follow the US Stock Market performance with the rate: -24.4%.
Estimated limits based on current volatility of 3.8%: low 4.51$, high 4.87$
Factors to consider:
- US accounted for 66.9% of revenue in the fiscal year ended 2023-12-31
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [3.80$, 7.85$]
- 2024-12-30 to 2025-12-30 estimated range: [3.12$, 6.79$]
Financial Metrics affecting the ARDX estimates:
- Negative: Non-GAAP EPS, $ of -0.30 <= 0.10
- Negative: Operating profit margin, % of -33.71 <= 1.03
- Negative: Operating cash flow per share per price, % of -7.05 <= 2.35
- Negative: negative Net income
- Positive: -0.96 < Investing cash flow per share, $ of -0.60
Short-term ARDX quotes
Long-term ARDX plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $10.10MM | $52.16MM | $124.46MM |
| Operating Expenses | $164.44MM | $115.92MM | $187.73MM |
| Operating Income | $-154.35MM | $-63.76MM | $-63.28MM |
| Non-Operating Income | $-3.81MM | $-3.44MM | $-2.24MM |
| Interest Expense | $4.50MM | $5.07MM | $8.87MM |
| R&D Expense | $91.14MM | $35.20MM | $35.54MM |
| Income(Loss) | $-158.16MM | $-67.20MM | $-65.52MM |
| Taxes | $0.00MM | $0.01MM | $0.55MM |
| Profit(Loss) | $-158.16MM | $-67.21MM | $-66.07MM |
| Stockholders Equity | $82.62MM | $98.33MM | $166.82MM |
| Inventory | $0.00MM | $3.28MM | $12.45MM |
| Assets | $149.91MM | $190.07MM | $297.58MM |
| Operating Cash Flow | $-152.55MM | $-70.04MM | $-89.72MM |
| Capital expenditure | $1.87MM | $0.06MM | $0.34MM |
| Investing Cash Flow | $50.95MM | $18.41MM | $-131.25MM |
| Financing Cash Flow | $83.00MM | $75.34MM | $146.29MM |
| Earnings Per Share* | $-1.52 | $-0.42 | $-0.30 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.